These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 35699442)

  • 1. Candida parapsilosis Mdr1B and Cdr1B Are Drivers of Mrr1-Mediated Clinical Fluconazole Resistance.
    Doorley LA; Rybak JM; Berkow EL; Zhang Q; Morschhäuser J; Rogers PD
    Antimicrob Agents Chemother; 2022 Jul; 66(7):e0028922. PubMed ID: 35699442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical azole cross-resistance in Candida parapsilosis is related to a novel MRR1 gain-of-function mutation.
    Branco J; Ryan AP; Pinto E Silva A; Butler G; Miranda IM; Rodrigues AG
    Clin Microbiol Infect; 2022 Dec; 28(12):1655.e5-1655.e8. PubMed ID: 36028086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Investigation of mutations in transcription factors of efflux pump genes in fluconazole-resistant Candida albicans strains overexpressing the efflux pumps].
    Kalkandelen KT; Doluca Dereli M
    Mikrobiyol Bul; 2015 Oct; 49(4):609-18. PubMed ID: 26649419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidrug Transporters and Alterations in Sterol Biosynthesis Contribute to Azole Antifungal Resistance in Candida parapsilosis.
    Berkow EL; Manigaba K; Parker JE; Barker KS; Kelly SL; Rogers PD
    Antimicrob Agents Chemother; 2015 Oct; 59(10):5942-50. PubMed ID: 26169412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABC transporter Cdr1p contributes more than Cdr2p does to fluconazole efflux in fluconazole-resistant Candida albicans clinical isolates.
    Holmes AR; Lin YH; Niimi K; Lamping E; Keniya M; Niimi M; Tanabe K; Monk BC; Cannon RD
    Antimicrob Agents Chemother; 2008 Nov; 52(11):3851-62. PubMed ID: 18710914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.
    Sanglard D; Kuchler K; Ischer F; Pagani JL; Monod M; Bille J
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2378-86. PubMed ID: 8585712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Species distribution, azole resistance and related molecular mechanisms in invasive Candida parapsilosis complex isolates: Increase in fluconazole resistance in 21 years.
    Demirci-Duarte S; Arikan-Akdagli S; Gülmez D
    Mycoses; 2021 Aug; 64(8):823-830. PubMed ID: 33934400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the multi-drug resistance regulator MRR1, followed by loss of heterozygosity, are the main cause of MDR1 overexpression in fluconazole-resistant Candida albicans strains.
    Dunkel N; Blass J; Rogers PD; Morschhäuser J
    Mol Microbiol; 2008 Aug; 69(4):827-40. PubMed ID: 18577180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of Clinically Derived Mutations in the Gene Encoding the Zinc Cluster Transcription Factor Mrr2 to Fluconazole Antifungal Resistance and
    Nishimoto AT; Zhang Q; Hazlett B; Morschhäuser J; Rogers PD
    Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30833425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquired resistance or tolerance? - in search of mechanisms underlying changes in the resistance profile of Candida albicans and Candida parapsilosis as a result of exposure to methotrexate.
    Góralska K; Szybka M; Karuga FF; Pastuszak-Lewandoska D; Brzeziańska-Lasota E
    J Mycol Med; 2024 Jun; 34(2):101476. PubMed ID: 38507825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology and Molecular Basis of Resistance to Fluconazole Among Clinical Candida parapsilosis Isolates in Kuwait.
    Asadzadeh M; Ahmad S; Al-Sweih N; Khan Z
    Microb Drug Resist; 2017 Dec; 23(8):966-972. PubMed ID: 28353392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluconazole-resistant Candida parapsilosis strains with a Y132F substitution in the ERG11 gene causing invasive infections in a neonatal unit, South Africa.
    Magobo RE; Lockhart SR; Govender NP
    Mycoses; 2020 May; 63(5):471-477. PubMed ID: 32124485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in TAC1 and ERG11 are major drivers of triazole antifungal resistance in clinical isolates of Candida parapsilosis.
    Doorley LA; Barker KS; Zhang Q; Rybak JM; Rogers PD
    Clin Microbiol Infect; 2023 Dec; 29(12):1602.e1-1602.e7. PubMed ID: 37666448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms associated with Fluconazole resistance in clinical Candida albicans isolates from India.
    Mane A; Vidhate P; Kusro C; Waman V; Saxena V; Kulkarni-Kale U; Risbud A
    Mycoses; 2016 Feb; 59(2):93-100. PubMed ID: 26648048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Investigation of the expression levels of efflux pumps in fluconazole-resistant Candida albicans isolates].
    Gulat S; Doluca Dereli M
    Mikrobiyol Bul; 2014 Apr; 48(2):325-34. PubMed ID: 24819270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of fluconazole resistance in Candida albicans isolates from Japanese AIDS patients.
    Maebashi K; Niimi M; Kudoh M; Fischer FJ; Makimura K; Niimi K; Piper RJ; Uchida K; Arisawa M; Cannon RD; Yamaguchi H
    J Antimicrob Chemother; 2001 May; 47(5):527-36. PubMed ID: 11328762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The transcription factor Ndt80 does not contribute to Mrr1-, Tac1-, and Upc2-mediated fluconazole resistance in Candida albicans.
    Sasse C; Schillig R; Dierolf F; Weyler M; Schneider S; Mogavero S; Rogers PD; Morschhäuser J
    PLoS One; 2011; 6(9):e25623. PubMed ID: 21980509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
    Sanglard D; Coste AT
    Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of clonal fluconazole-resistant Candida parapsilosis clinical isolates in a multicentre laboratory-based surveillance study in India.
    Singh A; Singh PK; de Groot T; Kumar A; Mathur P; Tarai B; Sachdeva N; Upadhyaya G; Sarma S; Meis JF; Chowdhary A
    J Antimicrob Chemother; 2019 May; 74(5):1260-1268. PubMed ID: 30753525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The transcription factor Mrr1p controls expression of the MDR1 efflux pump and mediates multidrug resistance in Candida albicans.
    Morschhäuser J; Barker KS; Liu TT; BlaB-Warmuth J; Homayouni R; Rogers PD
    PLoS Pathog; 2007 Nov; 3(11):e164. PubMed ID: 17983269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.